Tag Archives: cancer treatment

Merck to Showcase Oncology Portfolio Advancements at ESMO 2023, Highlighting Key Cancer Treatment Breakthroughs

(IN BRIEF) Merck, a leading science and technology company, is set to present 28 abstracts at the 2023 European Society of Medical Oncology (ESMO) Annual Meeting in Madrid. These abstracts will showcase the latest research on Merck’s oncology portfolio, addressing … Read the full press release

AstraZeneca completes acquisition of Neogene Therapeutics, expanding its portfolio in immuno-oncology

(PRESS RELEASE) CAMBRIDGE, 16-Jan-2023 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced the completion of its acquisition of Neogene Therapeutics Inc. Neogene is a global clinical-stage biotechnology company that specializes in the discovery, … Read the full press release

EQT further invests in the healthcare sector with the acquisition of Integrated Clinical Oncology Network

EQT Infrastructure has agreed to acquire Icon Group from a consortium including Goldman Sachs Asset Management, QIC and Pagoda. Goldman Sachs Asset Management will remain a minority shareholder as part of the transaction Icon Group is Australia’s largest vertically integrated cancer … Read the full press release

Paul Scherrer Institute PSI inaugurates new treatment unit for proton therapy against cancer

With millimetre precision, certain tumours can be irradiated at the Paul Scherrer Institute PSI using protons – that is, positively charged elementary particles. PSI is the one place in Switzerland where this especially protective and precise option for radiation therapy … Read the full press release

QIAGEN receives worldwide license from The Johns Hopkins University for biomarkers for immune-oncology therapies in cancer treatment

Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland, 07-Jun-2017 — /EuropaWire/ — QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide … Read the full press release

Bristol-Myers Squibb and QIAGEN to explore NGS technology to develop GEPs for I-O therapies in cancer treatment

NEW YORK and HILDEN, Germany, 06-Jun-2017 — /EuropaWire/ — Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as  … Read the full press release

University of Copenhagen: international scientists developed a method to help shorten the road to better cancer treatment

In collaboration with international scientists, researchers from the University of Copenhagen have developed a method to help shorten the road to better cancer treatment COPENHAGEN, 12-5-2015 — /EuropaWire/ — Danish researchers at the University of Copenhagen have discovered how to … Read the full press release